🇺🇸 Pneumovax in United States

1,352 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 1,352

Most-reported reactions

1. Fatigue — 177 reports (13.09%)
2. Pain — 157 reports (11.61%)
3. Dyspnoea — 149 reports (11.02%)
4. Headache — 140 reports (10.36%)
5. Nausea — 133 reports (9.84%)
6. Pneumonia — 129 reports (9.54%)
7. Cough — 125 reports (9.25%)
8. Chronic Kidney Disease — 117 reports (8.65%)
9. Diarrhoea — 114 reports (8.43%)
10. Pyrexia — 111 reports (8.21%)

Source database →

Frequently asked questions

Is Pneumovax approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pneumovax in United States?

VA Office of Research and Development is the originator. The local marketing authorisation holder may differ — check the official source linked above.